Study online at https://quizlet.com/_dmsqub
1. Nurse practitioner prescriptive authority is regulated C. The State Board of
by: Nursing for each state
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
2. Physician Assistant (PA) prescriptive authority is regu- D. The State Board of
lated by: Medical Examiners
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
3. Clinical judgment in prescribing includes: A. Factoring in the cost to
A. Factoring in the cost to the patient of the medica- the patient of the medica-
tion prescribed tion prescribed
B. Always prescribing the newest medication available
for the disease process C. Handing out drug samples
to poor patients
D. Prescribing all generic medications to cut costs
4. Criteria for choosing an effective drug for a disorder B. Consulting nationally
include: recognized guidelines for
A. Asking the patient what drug they think would work disease management
best for them
B. Consulting nationally recognized guidelines for dis-
ease management
C. Prescribing medications that are available as sam-
ples before writing a prescription
D. Following U.S. Drug Enforcement Administration
(DEA) guidelines for prescribing
, Nur 600 - Exam 1
Study online at https://quizlet.com/_dmsqub
5. Nurse practitioner practice may thrive under A. The demonstrated abili-
health-care reform due to: ty of nurse practitioners to
A. The demonstrated ability of nurse practitioners to control costs and improve
control costs and improve patient outcomes patient outcomes
B. The fact that nurse practitioners will be able to
practice independently
C. The fact that nurse practitioners will have full reim-
bursement under health-care reform
D. The ability to shift accountability for Medicaid to the
state level
6. A patient's nutritional intake and lab work reflects A. Distribution of drugs to
hypoalbuminemia. This is critical to prescribing be- target tissue may be af-
cause: fected
A. Distribution of drugs to target tissue may be affect-
ed
B. The solubility of the drug will not match the site of
absorption
C. There will be less free drug available to generate an
effect
D. Drugs bound to albumin are readily excreted by the
kidney
7. Drugs that have a significant first-pass effect: A. Must C. Are rapidly metabolized
be given by the enteral (oral) route only by the liver and may have
B. Bypass the hepatic circulation little if any desired action
C. Are rapidly metabolized by the liver and may have
little if any desired action
D. Are converted by the liver to more active and fat-sol-
uble forms
8. B. The lungs
, Nur 600 - Exam 1
Study online at https://quizlet.com/_dmsqub
The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin
9. Medroxyprogesterone (Depo Provera) is prescribed C. Increase the length of
IM to create a storage reservoir of the drug. Storage time a drug is available
reservoirs: and active
A. Assure that the drug will reach its intended target
tissue
B. Are the reason for giving loading doses
C. Increase the length of time a drug is available and
active
D. Are most common in collagen tissues
10. The NP chooses to give cephalexin every 8 hours B. Biological half-life
based on knowledge of the drug's:
A. Propensity to go to the target receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects
11. Azithromycin dosing requires the first day's dose be A. Rapidly achieves drug
twice those of the other 4 days of the prescription. levels in the therapeutic
This is considered a loading dose. A loading dose: A. range
Rapidly achieves drug levels in the therapeutic range
B. Requires four to five half-lives to attain
C. Is influenced by renal function
D. Is directly related to the drug circulating to the
target tissues
12. C. Onset of action
, Nur 600 - Exam 1
Study online at https://quizlet.com/_dmsqub
The point in time on the drug concentration curve that
indicates the first sign of a therapeutic effect is the:
A. Minimum adverse effect level
B. Peak of action
C. Onset of action
D. Therapeutic range
13. Phenytoin requires a trough level be drawn. Peak and D. To determine if a drug
trough levels are done: A. When the drug has a wide is in the therapeutic range
therapeutic range
B. When the drug will be administered for a short time
only
C. When there is a high correlation between the dose
and saturation of receptor sites
D. To determine if a drug is in the therapeutic range
14. A laboratory result indicates the peak level for a B. Concentration will pro-
drug is above the minimum toxic concentration. This duce an adverse response
means that the:
A. Concentration will produce therapeutic effects
B. Concentration will produce an adverse response
C. Time between doses must be shortened
D. Duration of action of the drug is too long
15. Drugs that are receptor agonists may demonstrate C. Desensitization or
what property? down-regulation with
A. Irreversible binding to the drug receptor site continuous use
B. Up-regulation with chronic use
C. Desensitization or down-regulation with continu-
ous use
D. Inverse relationship between drug concentration
and drug action